Table 1 The demographic and clinical characteristics of PD patients
Item | mean ± SD | Range |
|---|---|---|
Number of cases | 217 | |
Male, n(%) | 120 (55.3 %) | |
Age, year | 67.15 ± 0.61 | 40-85 |
Disease duration, year | 5.78 ± 4.32 | 1-23 |
H&Y stage | 1.43 ± 0.55 | 1-4 |
Use of levodopa, n(%) | 193 (88.9 %) | |
Use of DA agonists, n(%) | 101 (46.5 %) | |
Levodopa, (mg/d) | 494.94 ± 348.03 | 100-2825 |
DA agonist LED, (mg/d) | 135.15 ± 66.8 | 50-300 |
TLED, (mg/d) | 548.53 ± 382.12 | 50-3000 |